K. Moulton

Mortality in the Survival With ORal D-sotalol (SWORD) trial: why did patients die?

A. Camm, P. Schwartz, B. Pitt, 1998, The American journal of cardiology.

The safety and 24-hour antihypertensive efficacy of the vasopeptidase inhibitor Omapatrilat: a pilot study

R. Guthrie, M. Ruddy, R. Saini, 1999 .